» Articles » PMID: 16360418

CD14 and CD169 Expression in Human Lymph Nodes and Spleen: Specific Expansion of CD14+CD169- Monocyte-derived Cells in Diffuse Large B-cell Lymphomas

Overview
Journal Hum Pathol
Specialty Pathology
Date 2005 Dec 20
PMID 16360418
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The mononuclear phagocyte system of human lymphoid tissue comprises macrophages and dendritic cells (DCs). The heterogeneity of the non-DC mononuclear phagocyte population in human lymphoid tissue has been little addressed. Here, we studied the expression of 2 monocyte-derived markers, CD14 and CD169 (sialoadhesin), in reactive human lymphoid tissue as well as in a series of 51 B-cell lymphomas by immunohistochemistry on paraffin-embedded tissue. We confirmed that lymph node sinusoidal monocyte-derived cells were the only population staining for CD169. Although most sinusoidal histiocytes also expressed CD14, monocyte-derived cells with phagocytosis such as erythrophagocytosis, anthracosis, or tingible bodies macrophage lacked CD14 and CD169. Among B-cell lymphomas, splenic marginal zone lymphoma was the only one associated with an expansion of the CD14(+)CD169(+) cells in the cords. With respect to nodal B-cell lymphomas, CD14(+) cells were rare among B-chronic lymphocytic leukemia, follicular lymphoma (FL), mantle cell lymphoma (MCL). However, strikingly, we found a strong expansion of CD14(+)CD169(-) cells in numerous diffuse large B-cell lymphomas (DLBCLs), except in cases associated with numerous mitoses, apoptotic bodies, and tingible bodies macrophages. When cultivated in granulocyte/macrophage colony stimulating factor/interleukin 4, DLBCL purified CD14(+) cells differentiate into plasmacytoid cells, expressing DC-specific intercellular adhesion molecule 3-grabbing nonintegrin, suggesting dendritic cell differentiation potential. Our observation fits well with the lymph node and host response cluster signatures described in the gene profiling signatures of DLBCL. However, the role of this CD14(+) population that may constitute a microenvironment-related marker of this subgroup of DLBCL remains to be determined.

Citing Articles

The Prognostic Impact of Tumor Microenvironment and Checkpoint Blockade-Associated Molecules (PD-1, PD-L1, CD163 and CD14) in Nodal Diffuse Large B-cell Lymphoma, NOS.

Atmis O, Nese N, Aydogdu I, Alaca I, Mavili H, Isisag A Indian J Hematol Blood Transfus. 2024; 40(2):340-345.

PMID: 38708156 PMC: 11065815. DOI: 10.1007/s12288-023-01667-w.


Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications.

Georgoulis V, Papoudou-Bai A, Makis A, Kanavaros P, Hatzimichael E Biology (Basel). 2023; 12(6).

PMID: 37372147 PMC: 10294989. DOI: 10.3390/biology12060862.


Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma.

Scholler N, Perbost R, Locke F, Jain M, Turcan S, Danan C Nat Med. 2022; 28(9):1872-1882.

PMID: 36038629 PMC: 9499856. DOI: 10.1038/s41591-022-01916-x.


Functions of CD169 positive macrophages in human diseases (Review).

Liu Y, Xia Y, Qiu C Biomed Rep. 2021; 14(2):26.

PMID: 33408860 PMC: 7780751. DOI: 10.3892/br.2020.1402.


Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies.

Petty A, Yang Y Cells. 2019; 8(12).

PMID: 31783588 PMC: 6952752. DOI: 10.3390/cells8121526.